Literature DB >> 10850643

Normal circulating adult human red blood cells contain inactive NOS proteins.

E S Kang1, K Ford, G Grokulsky, Y B Wang, T M Chiang, S R Acchiardo.   

Abstract

Human red blood cells (RBCs) are considered to play a significant role in both blood pressure (BP) regulation and tissue oxygenation, because they can bind as well as release previously bound nitric oxide (NO) from hemoglobin (Hb) and other intracellular components. Two reports indicate that the human RBC possesses nitric oxide synthase (NOS) activity-by the accumulation of nitrite across a membraned chamber in one and by the hydrolysis of labeled L-arginine, presumably to labeled L-citrulline, in the other. Furthermore, NOS proteins have been identified by immunoblot in RBCs. If true, the presence of NOS activity would convert the human RBC to a donor with limited ability to bind exogenously generated NO. In considering the importance of the question of the presence or not of NO synthetic capacity of this cell in BP regulation and tissue perfusion, whether human RBCs are, indeed, able to hydrolyze L-arginine to L-citrulline, the coproduct of NO was explored. RBC samples collected from control subjects were assayed for NOS activity by incubation of homogenized cellular fractions with labeled tritiated L-arginine in the presence of 0.5 mmol/L NADPH. By this method, the amino acid coproduct of NO, tritiated L-citrulline, would be recovered in the supernatant after removal of unused substrate by cationic resin treatment. At first, activity appeared to be present in the RBC supernatant but not in the pellet. However, activity was not suppressed by known inhibitors of NOS, whereas activity was suppressed by norvaline, an inhibitor of arginase activity with no known effect on NOS. By contrast, RBC arginase activity was not inhibited by N(omega)-nitro-L-arginine, NG-methyl-L-arginine, or aminoguanidine, known inhibitors of NOS, but was inhibited by norvaline. The label recovered by thin-layer chromatography was determined not to be tritiated L-citrulline but was instead tritiated L-ornithine, the product of arginase activity. Thus the enzymatic hydrolysis of L-arginine was not caused by NOS but was a result of the action of the enzyme arginase, which abounds in this cell. However, proteins interacting with antibodies to the endothelial and inducible isoforms of NOS were detected in human RBCs by immunoblot. Together, these findings indicate that human RBCs collected from normal adult individuals possess proteins that react with monoclonal antibodies to the Inducible and endothelial isoforms of NOS, but the proteins are without catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10850643     DOI: 10.1067/mlc.2000.106805

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

Review 1.  Routes for formation of S-nitrosothiols in blood.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

2.  Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity.

Authors:  Jiangning Yang; Adrian T Gonon; Per-Ove Sjöquist; Jon O Lundberg; John Pernow
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 3.  Endothelial nitric oxide synthase in the microcirculation.

Authors:  Xiaohong Shu; T C Stevenson Keller; Daniela Begandt; Joshua T Butcher; Lauren Biwer; Alexander S Keller; Linda Columbus; Brant E Isakson
Journal:  Cell Mol Life Sci       Date:  2015-08-25       Impact factor: 9.261

Review 4.  Nitric oxide signaling in the microcirculation.

Authors:  Donald G Buerk; Kenneth A Barbee; Dov Jaron
Journal:  Crit Rev Biomed Eng       Date:  2011

5.  Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.

Authors:  Vladan P Cokic; Silvana A Andric; Stanko S Stojilkovic; Constance T Noguchi; Alan N Schechter
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

6.  Hemorrhagic shock and nitric oxide release from erythrocytic nitric oxide synthase: a quantitative analysis.

Authors:  Kejing Chen; Roland N Pittman; Aleksander S Popel
Journal:  Microvasc Res       Date:  2009-03-10       Impact factor: 3.514

7.  Arginase inhibition alleviates hypertension in the metabolic syndrome.

Authors:  Hany M El-Bassossy; Rania El-Fawal; Ahmed Fahmy; Malcolm L Watson
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 8.  Nitric oxide production pathways in erythrocytes and plasma.

Authors:  Kejing Chen; Aleksander S Popel
Journal:  Biorheology       Date:  2009       Impact factor: 1.875

9.  RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability.

Authors:  Marijke Grau; Sebastian Pauly; Jamal Ali; Katja Walpurgis; Mario Thevis; Wilhelm Bloch; Frank Suhr
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.

Authors:  Sonia Eligini; Benedetta Porro; Alessandro Lualdi; Isabella Squellerio; Fabrizio Veglia; Elisa Chiorino; Mauro Crisci; Anna Garlaschè; Marta Giovannardi; Josè-Pablo Werba; Elena Tremoli; Viviana Cavalca
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.